Ellison, C, Blackburn, K, Carmichael, P, Clewell, H, Cronin, MTD, Desprez, B, Escher, S, Ferguson, S, Grégoire, S, Hewitt, N, Hollnagel, H, Klaric, M, Patel, A, Salhi, S, Schepky, A, Schmitt, B, Wambaugh, J and Worth, A (2019) Challenges in working towards an internal Threshold of Toxicological Concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop. Regulatory Toxicology and Pharmacology. ISSN 0273-2300
|
Text
Challenges in working towards an internal Threshold of Toxicological Concern (iTTC) for use in the safety assessment of cosmetics Discussions from the Cosmetics Europe iTTC Working Group workshop.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (620kB) | Preview |
Abstract
The Threshold of Toxicological Concern (TTC) is an important risk assessment tool which establishes acceptable low-level exposure values to be applied to chemicals with limited toxicological data. One of the logical next steps in the continued evolution of TTC is to develop this concept further so that it is representative of internal exposures (TTC based on plasma concentration). An internal TTC (iTTC) would provide threshold values that could be utilized in exposure-based safety assessments. As part of a Cosmetics Europe (CosEu) research program, CosEu has initiated a project that is working towards the development of iTTCs that can be used for the human safety assessment. Knowing that the development of an iTTC is an ambitious and broad-spanning topic, CosEu organized a Working Group comprised a balance of multiple stakeholders (cosmetics and chemical industries, the EPA and JRC and academia) with relevant experience and expertise and workshop to critically evaluate the requirements to establish an iTTC. Outcomes from the workshop included an evaluation on the current state of the science for iTTC, the overall iTTC strategy, selection of chemical databases, capture and curation of chemical information, ADME and repeat dose data, expected challenges, as well as next steps and ongoing work.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 1115 Pharmacology and Pharmaceutical Sciences |
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
Divisions: | Pharmacy & Biomolecular Sciences |
Publisher: | Elsevier |
Date Deposited: | 18 Jan 2019 10:20 |
Last Modified: | 04 Sep 2021 09:48 |
DOI or ID number: | 10.1016/j.yrtph.2019.01.016 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/9970 |
View Item |